1315 collects $500m across two funds

• The investors for both funds include endowments, foundations, public and private pensions, business entities, and family offices
• Both Fund III and EGB target investments in commercial-stage healthcare businesses that have the potential to scale from $50 million to $150 million of revenue
• 1315 Capital has over $1 billion of assets under management

1315 Capital has raised $500 million across two funds: 1315 Capital III and 1315 Capital Emerging Growth and Buyout.

Fund III beat its $350 million target while EGB exceeded its $150 million target.

The investors for both funds include endowments, foundations, public and private pensions, business entities, and family offices.

“We are grateful for the partnership of existing and new investors as we continue to support exceptional healthcare teams and companies,” said Adele C. Oliva, a founding partner at 1315 Capital in a statement.

Both Fund III and EGB target investments in commercial stage healthcare businesses that have the potential to scale from $50 million to $150 million of revenue.

Based in Philadelphia, 1315 Capital backs commercial-stage healthcare services, pharmaceutical & medical technology outsourcing, medical technology, and health & wellness companies. 1315 Capital has over $1 billion of assets under management.